Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cardiol Therapeutics (NQ: CRDL ) 1.905 -0.085 (-4.27%) Streaming Delayed Price Updated: 3:14 PM EST, Nov 11, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Cardiol Therapeutics < Previous 1 2 Next > Why Cardiol Therapeutics (CRDL) Stock Is Down 20% Today October 09, 2024 Cardiol Therapeutics shares are trading lower by 20% Wednesday morning. The company announced a $13.5 million public offering. Via Benzinga AZZ, Helen of Troy And 3 Stocks To Watch Heading Into Wednesday October 09, 2024 Via Benzinga CRDL Stock Earnings: Cardiol Therapeutics Beats EPS for Q2 2024 August 12, 2024 CRDL stock results show that Cardiol Therapeutics beat analyst estimates for earnings per share the second quarter of 2024. Via InvestorPlace Hope on the Horizon: Results from MAvERIC-Pilot Show Heartfelt Progress for Patients June 17, 2024 Hope on the Horizon: Results from MAvERIC-Pilot Show Heartfelt Progress for Patients Via News Direct Exposures Product Safety Analysts’ Consensus Reaffirms Significant Upside Potential for Cardiol Therapeutics May 28, 2024 Analysts’ Consensus Reaffirms Significant Upside Potential for Cardiol Therapeutics Via News Direct Stocks That Hit 52-Week Lows On Wednesday October 19, 2022 On Wednesday, 200 companies hit new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Friday March 11, 2022 During Friday's session, 198 companies made new 52-week lows. Key Facts About Today's 52-Week Highs And Lows: Alibaba Group Holding (NYSE:BABA) is the largest... Via Benzinga CRDL Stock Earnings: Cardiol Therapeutics Meets EPS for Q1 2024 May 14, 2024 CRDL stock results show that Cardiol Therapeutics met analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Weighs In May 14, 2024 Roy Bingham, CEO of BDSA, anticipates substantial growth in the U.S. cannabis market, projecting sales to reach nearly $46 billion by 2028. Via Benzinga Topics Cannabis Exposures Cannabis CRDL Stock Earnings: Cardiol Therapeutics Beats EPS for Q4 2023 April 02, 2024 CRDL stock results show that Cardiol Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023. Via InvestorPlace Cardiol Therapeutics - This Penny Stock Is An Analysts Favorite January 31, 2024 Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies. Via Talk Markets Cardiol Therapeutics (NASDAQ: CRDL) Advancements in Therapies for Inflammatory Heart Diseases October 13, 2023 --News Direct-- Via News Direct Topics Death Exposures Death Cardiol Therapeutics Fights Heart Inflammation With Novel Formulations October 12, 2023 697,000 people die from heart disease every year in the United States – that is one in every five deaths. Via Benzinga CBD To Treat Heart Failure? New Study Shows Its Cardioprotective Effects October 10, 2023 On Tuesday, Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) announced positive study results demonstrating that subcutaneously administered cannabidiol - the active pharmaceutical ingredient in... Via Benzinga Why Murphy Canyon Acquisition Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket September 21, 2023 Gainers Near Intelligence, Inc. (NASDAQ: NIR) shares rose 34.1% to $0.2801 in pre-market trading after falling 42% on Wednesday. Near Intelligence recently named its General Counsel, Jay Angelo, to... Via Benzinga Stocks That Hit 52-Week Lows On Tuesday October 04, 2022 On Tuesday, 44 companies hit new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Tuesday October 18, 2022 During Tuesday's session, 78 companies made new 52-week lows. Via Benzinga FDA Clears Cardiol Therapeutics' IND for CardiolRx in Recurrent Pericarditis May 17, 2022 The U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug Application (IND) from Cardiol Therapeutics Inc. (NASDAQ: CRDL) to start a Phase 2 open-label pilot study designed... Via Benzinga 76 Biggest Movers From Yesterday May 19, 2022 Gainers Bright Green Corp. (NASDAQ: BGXX) jumped 90.5% to close at $48.08 on Wednesday. Bright Green Corporation, went public on the NASDAQ Tuesday, becoming the first U.S. plant-touching company to... Via Benzinga 34 Stocks Moving In Monday's Mid-Day Session April 18, 2022 Gainers Casa Systems, Inc. (NASDAQ: CASA) shares climbed 66.3% to $6.47 after the company announced a multi-year contract with Verizon to provide 5G core network functions.... Via Benzinga 68 Biggest Movers From Yesterday April 19, 2022 Gainers Casa Systems, Inc. (NASDAQ: CASA) shares surged 82.5% to close at $7.10 on Monday after the company announced a multi-year contract with Verizon to provide 5G core... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2022 March 17, 2022 Upgrades Loop Capital upgraded the previous rating for Aspen Technology Inc (NASDAQ:AZPN) from Hold to Buy. In the second quarter, Aspen Technology showed an EPS of $1.20,... Via Benzinga 51 Biggest Movers From Thursday April 18, 2022 Gainers MedAvail Holdings, Inc. (NASDAQ: MDVL) shares surged 69.4% to close at $2.44 on Thursday. Ally Bridge Group recently reported a purchase of 21.176 million shares of... Via Benzinga Cardiol Therapeutics To Include Vaccinated Participants In Cannabidiol COVID-19 Trial March 01, 2022 The FDA and regulatory agencies in Brazil & Mexico have cleared Cardiol Therapeutics Inc (NASDAQ: CRDL) to modify the inclusion criteria for the LANCER trial to... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday January 18, 2022 I hope you enjoyed the long weekend, but it's time to get back into investing with the biggest pre-market stock movers for Tuesday! Via InvestorPlace 52 Biggest Movers From Yesterday January 20, 2022 Gainers Zogenix, Inc. (NASDAQ: ZGNX) shares surged 65.7% to close at $25.92 on Wednesday after the company announced it will be acquired by UCB for approximately $1.9 billion. G... Via Benzinga 65 Biggest Movers From Yesterday January 19, 2022 Gainers Brickell Biotech, Inc. (NASDAQ: BBI) shares jumped 58.6% to settle at $0.33 on Tuesday after HC Wainwright & Co initiated coverage on the stock with a Buy rating and... Via Benzinga 52 Biggest Movers From Friday January 18, 2022 Gainers Splash Beverage Group, Inc. (NASDAQ: SBEV) shares gained 118.9% to settle at $4.18 on Friday. Splash Beverage recently announced it has received authorization to sell its... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For December 17, 2021 December 17, 2021 Upgrades According to Morgan Stanley, the prior rating for Definitive Healthcare Corp (NASDAQ: Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For December 3, 2021 December 03, 2021 Upgrades Cowen & Co. upgraded the previous rating for Marvell Technology Inc (NASDAQ: Via Benzinga < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
